Adjuvance Technologies

Stephan Schulze joined Adjuvance Technologies as its Chief Financial Officer in 2019. From 2017-2019 Mr. Schulze served as the CFO of Ceva US Holdings, Inc. In 2014 he joined Continental Disc Corporation as its CFO. Between 2007 and 2014 he worked for different affiliates of Boehringer Ingelheim as Director of Finance, initially as Director Marketing & Sales Controlling and finally as Director of Operations Controlling. During that time he was in charge of the financial integration of the acquired Fort Dodge Animal Health business. Mr. Schulze worked at Eli Lilly and Company in various finance roles and locations between 1999 – 2007. He started his career in finance working for Mercedes-Benz in 1994. His educational background includes a Diplom-Betriebswirt (BA) from Verwaltungs-und Wirtschaftsakademie, Stuttgart, and a Master of Business Administration from Vanderbilt University.